AT274248B - Process for the preparation of new derivatives of bufadienolide glycosides - Google Patents

Process for the preparation of new derivatives of bufadienolide glycosides

Info

Publication number
AT274248B
AT274248B AT1181367A AT1181367A AT274248B AT 274248 B AT274248 B AT 274248B AT 1181367 A AT1181367 A AT 1181367A AT 1181367 A AT1181367 A AT 1181367A AT 274248 B AT274248 B AT 274248B
Authority
AT
Austria
Prior art keywords
bufadienolide
glycosides
preparation
new derivatives
general formula
Prior art date
Application number
AT1181367A
Other languages
German (de)
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Application granted granted Critical
Publication of AT274248B publication Critical patent/AT274248B/en

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

   <Desc/Clms Page number 1> 
 



  Verfahren zur Herstellung neuer Derivate von Bufadienolidglykosiden 
Die Erfindung betrifft ein Verfahren zur Herstellung neuer Derivate von Bufadienolidglykosiden der allgemeinen Formel 
 EMI1.1 
 
In dieser Formel bedeuten   R,   ein Wasserstoffatom oder den Acetylrest, Rz und   Rs,   die gleich oder verschieden sein können, Wasserstoffatome, gegebenenfalls halogensubstituierte Alkylreste oder zusamsen, mit dem benachbarten Kohlenstoffatom einen alicyclischen Ring mit 5 bis 7 Kohlenstoffatomen. 



   Die neuen Verbindungen sind also Derivate des   Scilliglaucosidin-a-L-rhamnosids.   Das Scilliglau-   cosidin-a-L-rhamnosid   selbst ist eine neue Verbindung, die aus den bei der Gewinnung des Proscillaridin A anfallenden Mutterlaugen isoliert werden kann. Diese Mutterlaugen werden zunächst 45 min mit piger Schwefelsäure in 50%igem Methanol unter Rückfluss gekocht, wobei das Proscillaridin A gespalten wird, nicht jedoch das   Scilliglaucosidin-a-L-rhamnosid.   Letzteres wird von dem Aglykon des Proscillaridin A durch Säulenchromatographie an wasserhaltigem Kieselgel mittels eines Gemisches von Methylenchlorid und Methanol im Verhältnis 100 : 5 getrennt.

   Der Schmelzpunkt der reinen Verbin- 
 EMI1.2 
 

 <Desc/Clms Page number 2> 

 beträgt-470 20 (c = 1, Me-Erfindungsgemäss werden die neuen Verbindungen durch Umsetzung einer Verbindung der allgemeinen Formel 
 EMI2.1 
 mit einer Verbindung der allgemeinen Formel 
 EMI2.2 
 
 EMI2.3 
 

 <Desc/Clms Page number 3> 

 Die Umsetzung wird dünnschichtchromatographisch verfolgt. Nach beendeter Reaktion wird das Kupfersulfat über einen Filter, abgedichtet mit Aluminiumoxyd   (AO   nach Woelm Aktiv. Stufe I), abgesaugt. Das klare Filtratwird zur Trockene eingeengt und aus 60 ml Methanol umkristallisiert. Die Substanz kristallisiert in farblosen Stäbchen. 



     Ausbeute : 1, 4   g (87,   00/0   der Theorie)
F. : 164 bis 1670 C   (Zers.).   



    B eis pi el 2 : 3B- (2I, 31-0-Isopropyliden-41-acetyl) -a-L-rhamnosido-14B-hydroxy-19-oxo-bufa-    - 4, 20,22-trienolid. 



   1, 6 g   3ss- (2t, 31-0-Isopropyliden)-a-L-rhamnosido-14ss-hydroxy-19-oxo-bufa-4,   20,22-trienolid, gelöst in 12,0 ml Pyridin und 8,0 ml Acetanhydrid, werden 24 h bei 200 C stehengelassen. Das Ende der Reaktion wird dünnschichtchromatographisch festgestellt. Nach beendeter Reaktion wird imVakuum bei 500 C zur Trockene eingeengt. Der sirupartige Rückstand wird in 50 ml Chloroform gelöst und mit Wasser 2n HCl, Wasser, 2n Sodalösung und Wasser gewaschen. Nach Trocknen über Natriumsulfat wird erneut im Vakuum zur Trockene eingeengt. Der farblose, amorphe Rückstand wird aus 40 ml warmem Methanol umkristallisiert. Die Substanz kristallisiert in farblosen Nadeln. 



   Ausbeute : 1, 3 g (76,   oxo   der Theorie)
F. : 228 bis 2310 C   (Zers.).   



    B e i s p i e l 3: 3ss-(2',3'-O-Methyl-propyliden)-&alpha;-L-rhamnosido-14ss-hydroxy-19-oxo-bufa-4,20,   22-trienolid
200 mg   3ss-ct-L-Rhamnosido-14ss-hydroxy-19-oxo-bufa-4,   20,22-trienolid, 1, 5 g Kupfersulfat und 80 ml Methyläthylketon werden analog Beispiel 1 umgesetzt und aufgearbeitet. Umkristallisation aus Äther : n-Hexan = 6 : 1 ergeben 130 mg weisse Kristalle (59% der Theorie) vom
Fp. : 143 bis 1460 C. 



     B e i s p i e l 4: 3ss-(2',3'-O-Trichloräthyliden)-&alpha;-L-rahmnosido-14ss-hydroxy-19-oxo-bufa-4,   20, 22-trienolid 
 EMI3.1 
 abdestilliert, der Rückstand in Chloroform gelöst und gewaschen und zur Trockene eingeengt. Umkristallisation aus Äther : n-Hexan = 5 : 1 ergeben 53 mg gelbliche Kristalle in Blättchenform (43% der Theorie) vom
Fp. : 80 bis 860 C. 

**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.



   <Desc / Clms Page number 1>
 



  Process for the preparation of new derivatives of bufadienolide glycosides
The invention relates to a process for the preparation of new derivatives of bufadienolide glycosides of the general formula
 EMI1.1
 
In this formula, R, a hydrogen atom or the acetyl radical, Rz and Rs, which can be identical or different, denote hydrogen atoms, optionally halogen-substituted alkyl radicals or together with the adjacent carbon atom, an alicyclic ring having 5 to 7 carbon atoms.



   The new compounds are therefore derivatives of scilliglaucosidine-a-L-rhamnoside. The scilliglaucosidin-a-L-rhamnoside itself is a new compound that can be isolated from the mother liquors obtained during the production of proscillaridin A. These mother liquors are first refluxed for 45 minutes with pigerous sulfuric acid in 50% methanol, the proscillaridin A being cleaved, but not the scilliglaucosidin-a-L-rhamnoside. The latter is separated from the aglycon of proscillaridin A by column chromatography on water-containing silica gel using a mixture of methylene chloride and methanol in a ratio of 100: 5.

   The melting point of the pure compound
 EMI1.2
 

 <Desc / Clms Page number 2>

 is -470 20 (c = 1, Me-According to the invention, the new compounds are obtained by reacting a compound of the general formula
 EMI2.1
 with a compound of the general formula
 EMI2.2
 
 EMI2.3
 

 <Desc / Clms Page number 3>

 The reaction is followed by thin layer chromatography. After the reaction has ended, the copper sulphate is suctioned off through a filter sealed with aluminum oxide (AO according to Woelm Aktiv. Level I). The clear filtrate is concentrated to dryness and recrystallized from 60 ml of methanol. The substance crystallizes in colorless rods.



     Yield: 1.4 g (87.00/0 of theory)
F.: 164 to 1670 C (dec.).



    Example 2: 3B- (2I, 31-0-isopropylidene-41-acetyl) -a-L-rhamnosido-14B-hydroxy-19-oxo-bufa- -4, 20,22-trienolide.



   1.6 g of 3ss- (2t, 31-0-isopropylidene) -aL-rhamnosido-14ss-hydroxy-19-oxo-bufa-4, 20,22-trienolide, dissolved in 12.0 ml of pyridine and 8.0 ml Acetic anhydride, are left to stand at 200 ° C. for 24 hours. The end of the reaction is determined by thin layer chromatography. When the reaction has ended, the mixture is concentrated to dryness in vacuo at 500 ° C. The syrupy residue is dissolved in 50 ml of chloroform and washed with water, 2N HCl, water, 2N soda solution and water. After drying over sodium sulfate, it is again concentrated to dryness in vacuo. The colorless, amorphous residue is recrystallized from 40 ml of warm methanol. The substance crystallizes in colorless needles.



   Yield: 1.3 g (76, oxo of theory)
F.: 228 to 2310 C (dec.).



    Example 3: 3ss- (2 ', 3'-O-methyl-propylidene) -α-L-rhamnosido-14ss-hydroxy-19-oxo-bufa-4,20,22-trienolide
200 mg of 3ss-ct-L-rhamnosido-14ss-hydroxy-19-oxo-bufa-4, 20,22-trienolide, 1.5 g of copper sulfate and 80 ml of methyl ethyl ketone are reacted and worked up analogously to Example 1. Recrystallization from ether: n-hexane = 6: 1 gives 130 mg of white crystals (59% of theory) from
M.p .: 143 to 1460 C.



     Example 4: 3ss- (2 ', 3'-O-trichloroethylidene) -α-L-rahmnosido-14ss-hydroxy-19-oxo-bufa-4, 20, 22-trienolide
 EMI3.1
 distilled off, the residue dissolved in chloroform and washed and concentrated to dryness. Recrystallization from ether: n-hexane = 5: 1 gives 53 mg of yellowish crystals in flake form (43% of theory) from
M.p .: 80 to 860 C.

** WARNING ** End of DESC field may overlap beginning of CLMS **.

 

Claims (1)

PATENTANSPRÜCHEt 1. Verfahren zur Herstellung neuer Derivate von Bufadienolidglykosiden der allgemeinen Formel EMI3.2 in der R, Wasserstoff oder den Acetylrest und lu und Rg, die gleich oder verschieden sein können, Wasserstoffatome, gegebenenfalls halogensubstituierte Alkylreste oder zusammen mit dem benachbarten <Desc/Clms Page number 4> EMI4.1 EMI4.2 mit einer Verbindung der allgemeinen Formel EMI4.3 in der und Rg die angeführten Bedeutungen aufweisen, in Gegenwart eines wasserentziehenden Mittels umgesetzt wird und so erhaltene Verbindungen der Formel I, in der R Wasserstoff bedeutet, gewünschtenfalls nachträglich nach üblichen Methoden acetyliert werden. PATENT CLAIMS 1. Process for the preparation of new derivatives of bufadienolide glycosides of the general formula EMI3.2 in which R, hydrogen or the acetyl radical and lu and Rg, which can be identical or different, hydrogen atoms, optionally halogen-substituted alkyl radicals or together with the adjacent one <Desc / Clms Page number 4> EMI4.1 EMI4.2 with a compound of the general formula EMI4.3 in which and Rg have the meanings given, is reacted in the presence of a dehydrating agent and compounds of the formula I thus obtained, in which R is hydrogen, are, if desired, subsequently acetylated by customary methods. 2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, dass als wasserentziehendes Mittel wasserfreies Kupfersulfat verwendet wird. 2. The method according to claim 1, characterized in that anhydrous copper sulfate is used as the dehydrating agent.
AT1181367A 1966-12-30 1967-12-29 Process for the preparation of new derivatives of bufadienolide glycosides AT274248B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE274248X 1966-12-30

Publications (1)

Publication Number Publication Date
AT274248B true AT274248B (en) 1969-09-10

Family

ID=6019525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1181367A AT274248B (en) 1966-12-30 1967-12-29 Process for the preparation of new derivatives of bufadienolide glycosides

Country Status (1)

Country Link
AT (1) AT274248B (en)

Similar Documents

Publication Publication Date Title
CH637404A5 (en) METHOD FOR PRODUCING 17-ALPHA PREGENER DERIVATIVES.
AT274248B (en) Process for the preparation of new derivatives of bufadienolide glycosides
DE1962757B2 (en) Evomonoside derivatives, processes for their production and pharmaceuticals containing them
DE1172671B (en) Process for the preparation of 17ª-hydroxy-androstane-(3, 2-c)-pyrazole or a 17ª-hydroxy-17ª-lower-alkyl-androstane-(3, 2-c)-pyrazole
DE2436332A1 (en) SUBSTITUTED TETRAHYDROFURANS AND PROCESS FOR THEIR PRODUCTION
DE1807585C3 (en) 14,15beta-epoxy cardenolides, processes for their preparation and compositions containing them
DE1288602B (en) Process for making steroid compounds
DE1468517B1 (en) Oestran series steroids and process for their manufacture
DE2319873C2 (en) 16-O-alkyl derivatives of gitoxigenin digitoxosides, processes for their preparation and pharmaceuticals containing them
AT281303B (en) PROCESS FOR THE PREPARATION OF NEW DERIVATIVES OF BUFADIENOLIDE GLYCOSIDES
AT233174B (en) Process for the preparation of 3-keto-Δ4, 6-10 (α) -methyl steroids
DE750481C (en) Process for the production of compounds of des2-methyl-4-amino-naphthols- (1) which are stable in aqueous solutions
AT248622B (en) Process for the production of new 2-cyano-3-oxo-steroids
DE2661027C2 (en)
DE2016704C3 (en) A new, 14.15 ß-Oxidobufadienolide-LRhamnoside, active in the heart, and process for its preparation
DE1468517C (en) Ostran series steroids and processes for their manufacture
AT277474B (en) Process for the preparation of new derivatives of bufadienolide glycosides
AT275054B (en) Process for the production of new 9β, 10α-steroids
DE1939164A1 (en) 14beta-hydroxy-15alpha-acyloxy-cardenolide
CH514567A (en) 7 3 2-c-pyrazolo-pregnanes
AT240540B (en) Process for the preparation of 4-chloro-Δ &lt;4&gt; -3-ketosteroid compounds
AT292931B (en) Process for the production of new androstane derivatives
AT349030B (en) PROCESS FOR THE PRODUCTION OF NEW 8-HYDROXY-3-HALOGENMETHYL-4-ACETOXY-10-METHYLENE-2,9-DIOXATRICYCLO (4,3,1,03,7) DECANES OR OF THE APPROPRIATE 8-OXO DERIVATIVES
AT273387B (en) Process for the production of new cholesterol derivatives and their acid addition salts
DE2306580C2 (en) Process for the preparation of 16-acyl derivatives of gitoxigenin digitoxoside